Coramitug, a humanized monoclonal antibody for the treatment of transthyretin amyloid cardiomyopathy: a phase 2, randomized, multicenter, double-blind, placebo-controlled trial
by Fontana, Marianna (Author)
, García-Pavía, Pablo (Author)
, Grogan, Martha (Author)
, Shah, Sanjiv J. (Author)
, Engelmann, Mads D. M. (Author)
, Hovingh, G. Kees (Author)
, Kristen, Arnt (Author)
, Lim-Watson, Michelle Z. (Author)
, Malling, Brian (Author)
, Kar, Soumitra (Author)
, Revanna, Manjunatha (Author)
, Sarswat, Nitasha (Author)
, Tsujita, Kenichi (Author)
, Alexander, Kevin M. (Author)
, Maurer, Mathew S. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource